Man Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $73.1M | Buy |
134,890
+57,395
| +74% | +$32.3M | 0.12% | 197 |
|
|
2026
Q1 | $46M | Sell |
77,495
-1,507
| -2% | -$751K | 0.08% | 262 |
|
|
2025
Q4 | $38.5M | Buy |
79,002
+15,953
| +25% | +$7.43M | 0.07% | 295 |
|
|
2025
Q3 | $26.4M | Sell |
63,049
-41,887
| -40% | -$14.1M | 0.05% | 416 |
|
|
2025
Q2 | $30.2M | Buy |
104,936
+27,433
| +35% | +$8.2M | 0.06% | 370 |
|
|
2025
Q1 | $23.9M | Buy |
77,503
+30,780
| +66% | +$10.5M | 0.06% | 370 |
|
|
2024
Q4 | $16.5M | Buy |
46,723
+302
| +0.7% | +$111K | 0.04% | 513 |
|
|
2024
Q3 | $16.6M | Sell |
46,421
-28,898
| -38% | -$9.76M | 0.04% | 516 |
|
|
2024
Q2 | $24M | Sell |
75,319
-31,202
| -29% | -$8.26M | 0.06% | 377 |
|
|
2024
Q1 | $24.5M | Buy |
106,521
+71,681
| +206% | +$16.2M | 0.06% | 360 |
|
|
2023
Q4 | $7.66M | Buy |
+34,840
| New | +$8.03M | 0.02% | 776 |
|
|
2023
Q3 | – | Sell |
-15,111
| Closed | -$3.48M | – | 506 |
|
|
2023
Q2 | $3.34M | Buy |
+15,111
| New | +$3.35M | 0.01% | 1029 |
|
|
2023
Q1 | – | Sell |
-91,289
| Closed | -$22.5M | – | 329 |
|
|
2022
Q4 | $25.4M | Sell |
91,289
-32,526
| -26% | -$8.21M | 0.09% | 274 |
|
|
2022
Q3 | $25.9M | Buy |
+123,815
| New | +$27.7M | 0.12% | 213 |
|
|
2022
Q2 | – | Sell |
-67,736
| Closed | -$13.8M | – | 199 |
|
|
2022
Q1 | $12.2M | Buy |
67,736
+7,026
| +12% | +$1.34M | 0.04% | 529 |
|
|
2021
Q4 | $13.1M | Buy |
60,710
+38,600
| +175% | +$7.58M | 0.04% | 497 |
|
|
2021
Q3 | $4.08M | Sell |
22,110
-28,991
| -57% | -$5.71M | 0.01% | 921 |
|
|
2021
Q2 | $9.17M | Sell |
51,101
-32,856
| -39% | -$6.26M | 0.03% | 615 |
|
|
2021
Q1 | $14M | Sell |
83,957
-19,319
| -19% | -$3.22M | 0.06% | 334 |
|
|
2020
Q4 | $15.7M | Buy |
103,276
+92,908
| +896% | +$12.2M | 0.07% | 278 |
|
|
2020
Q3 | $1.05M | Sell |
10,368
-43,757
| -81% | -$4.8M | ﹤0.01% | 1361 |
|
|
2020
Q2 | $6.55M | Buy |
54,125
+51,414
| +1,896% | +$5.78M | 0.03% | 545 |
|
|
2020
Q1 | $257K | Buy |
+2,711
| New | +$258K | ﹤0.01% | 1419 |
|
|
2019
Q3 | – | Sell |
-13,891
| Closed | -$1.08M | – | 1921 |
|
|
2019
Q2 | $1.08M | Sell |
13,891
-22,330
| -62% | -$2.09M | ﹤0.01% | 1504 |
|
|
2019
Q1 | $4.25M | Sell |
36,221
-30,100
| -45% | -$3.51M | 0.02% | 1002 |
|
|
2018
Q4 | $7.22M | Sell |
66,321
-9,176
| -12% | -$1.06M | 0.03% | 585 |
|
|
2018
Q3 | $9.65M | Buy |
75,497
+28,918
| +62% | +$3.58M | 0.04% | 640 |
|
|
2018
Q2 | $5.27M | Buy |
46,579
+12,771
| +38% | +$1.4M | 0.02% | 922 |
|
|
2018
Q1 | $3.8M | Buy |
+33,808
| New | +$4.29M | 0.02% | 998 |
|
Other funds holding UTHR
ACA
JT
Man Group's UTHR Position: Q2 2026 in Review
Man Group increased its United Therapeutics (UTHR) stake by 74% in Q2 2026, buying an estimated $32.3M and bringing the position to 134,890 shares worth $73.1M. The position accounts for 0.12% of the portfolio, ranked #197.
Man Group first reported a position in UTHR in Q1 2018 and has held it in 29 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Man Group held 134,890 shares of United Therapeutics worth $73.1M as of Q2 2026.
- Man Group bought 57,395 United Therapeutics shares in Q2 2026, an estimated $32.3M.
- United Therapeutics made up 0.12% of Man Group's portfolio in Q2 2026, its #197 holding.
- Man Group first reported a position in United Therapeutics in Q1 2018 and has held it in 29 quarters since.
- 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.